Loading...
News & Insights2020-02-18T15:42:30+00:00

LTEN 2022

Thought Leadership|

Are you attending LTEN June 13- June 15 in San Antonio, Texas?

Don’t miss our workshop “Biosimilars: Shifting Access Strategies in the Payer and Health Systems Market” on June 15 at at 2:00 pm featuring Precision’s Ryan Cox, Erica Gaeta, and Dan Vanderpoel.

(more…)

CMS Rule on Pharma Patient-Assistance Programs Could Cut Back on Aid

Thought Leadership|

A rule slated to take effect January 1, 2023 would reverse CMS’ long held position that manufacturer-provided assistance given to patients is excluded from best price and average manufacturer price calculation for prescription drugs. The rule change could potentially result in increased patient out-of-pocket costs for drugs and pharma companies being on the hook for ensuring they know exactly where their assistance is going.

(more…)

CMS Targets Patient-Assistance Programs; Rule Could Curtail Aid

Thought Leadership|

CMS’s stance has long been that manufacturer-provided assistance given to patients is excluded from best price and average manufacturer price calculation for prescription drugs. However, the rise of copayment accumulators and maximizers and health insurers’ subsequent taking of this assistance rather than allowing it to count toward patients’ deductibles and out-of-pocket maximums have caused the agency to rethink its position. Precision’s Ryan Cox and Reta Mourad break down the implications of the proposed rule change, including the potential for increased patient out-of-pocket drug costs, pharma companies being on the hook for ensuring they know exactly where their assistance is going, and possible unintended consequences.

(more…)

Conference: Meeting on the Med, 2022

Events|

Precision will be at this year’s Meeting on the Med conference from April 20 – 22nd in Barcelona, Spain. Connect with our team of experts as they lead meaningful discussions throughout this event, providing insights into the clinical development, manufacturing, and commercialization of cell and gene therapies.

(more…)

The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation

Thought Leadership|

Over the last decade, healthcare costs have continued to rise in the United States while outcomes have been stagnant and, in some cases, declined. Implementation of strategies around patient- or consumer-driven care has been a struggle as stakeholders try to define, measure, and improve the patient experience.

(more…)

Load More Posts